Nektar Initiates Second Phase 1 Clinical Study Evaluating NKTR-181, a Novel

Oxycodone Addiction Treatment: Nektar Initiates Second Phase 1 Clinical Study Evaluating NKTR-181, A Novel
With slower entry into the CNS when compared to published oxycodone data, NKTR-181 has the potential to greatly reduce the euphoria that underlies opioid abuse liability and dependence. In addition, NKTR-181 is intended to reduce the other serious
Read more on MarketWatch (press release)



Oxycodone Addiction Treatment: Frustration over Vicodin-Hydrocodone Classification
The delay has been a source of increasing frustration for lawmakers, drug treatment counselors and the families of those who abuse prescription drugs. Hydrocodone is a prescription painkiller that is has a similar chemical makeup to oxycodone.
Read more on Stop Oxy

More Oxycodone Addiction Treatment Information…